Amdocs Stock Based Compensation To Revenue from 2010 to 2025

DOX Stock  USD 84.89  0.21  0.25%   
Amdocs Stock Based Compensation To Revenue yearly trend continues to be fairly stable with very little volatility. Stock Based Compensation To Revenue will likely drop to 0.01 in 2025. Stock Based Compensation To Revenue is a metric that compares the total value of stock-based compensation granted by Amdocs to its total revenue, indicating how much of the revenue is used to compensate employees with stock options or awards. View All Fundamentals
 
Stock Based Compensation To Revenue  
First Reported
2010-12-31
Previous Quarter
0.0188
Current Value
0.0107
Quarterly Volatility
0.00331087
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Amdocs financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Amdocs' main balance sheet or income statement drivers, such as Depreciation And Amortization of 183 M, Interest Expense of 42.1 M or Total Revenue of 3.2 B, as well as many indicators such as Price To Sales Ratio of 3.36, Dividend Yield of 0.0369 or PTB Ratio of 1.42. Amdocs financial statements analysis is a perfect complement when working with Amdocs Valuation or Volatility modules.
  
Check out the analysis of Amdocs Correlation against competitors.
For more information on how to buy Amdocs Stock please use our How to Invest in Amdocs guide.

Latest Amdocs' Stock Based Compensation To Revenue Growth Pattern

Below is the plot of the Stock Based Compensation To Revenue of Amdocs over the last few years. It is a metric that compares the total value of stock-based compensation granted by a company to its total revenue, indicating how much of the revenue is used to compensate employees with stock options or awards. Amdocs' Stock Based Compensation To Revenue historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Amdocs' overall financial position and show how it may be relating to other accounts over time.
Stock Based Compensation To Revenue10 Years Trend
Slightly volatile
   Stock Based Compensation To Revenue   
       Timeline  

Amdocs Stock Based Compensation To Revenue Regression Statistics

Arithmetic Mean0.01
Geometric Mean0.01
Coefficient Of Variation24.43
Mean Deviation0
Median0.01
Standard Deviation0
Sample Variance0.000011
Range0.0115
R-Value0.38
Mean Square Error0.00001
R-Squared0.14
Significance0.15
Slope0.0003
Total Sum of Squares0.0002

Amdocs Stock Based Compensation To Revenue History

2025 0.0107
2024 0.0188
2023 0.0209
2022 0.0184
2021 0.0157
2020 0.0126
2019 0.0102

About Amdocs Financial Statements

Amdocs investors use historical fundamental indicators, such as Amdocs' Stock Based Compensation To Revenue, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Amdocs. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Stock Based Compensation To Revenue 0.02  0.01 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Amdocs Stock Analysis

When running Amdocs' price analysis, check to measure Amdocs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amdocs is operating at the current time. Most of Amdocs' value examination focuses on studying past and present price action to predict the probability of Amdocs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amdocs' price. Additionally, you may evaluate how the addition of Amdocs to your portfolios can decrease your overall portfolio volatility.